Dana Investment Advisors Inc. Has $7.85 Million Holdings in Ingredion Incorporated (NYSE:INGR)

Dana Investment Advisors Inc. cut its position in Ingredion Incorporated (NYSE:INGR) by 3.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 57,052 shares of the company’s stock after selling 2,005 shares during the quarter. Dana Investment Advisors Inc. owned about 0.09% of Ingredion worth $7,848,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in INGR. Assetmark Inc. grew its position in shares of Ingredion by 38,341.7% in the 4th quarter. Assetmark Inc. now owns 509,352 shares of the company’s stock valued at $70,067,000 after acquiring an additional 508,027 shares during the period. Hennessy Advisors Inc. bought a new position in Ingredion during the fourth quarter worth about $58,642,000. Pacer Advisors Inc. increased its position in Ingredion by 16.5% during the fourth quarter. Pacer Advisors Inc. now owns 1,890,488 shares of the company’s stock worth $260,056,000 after buying an additional 268,389 shares during the last quarter. Caisse DE Depot ET Placement DU Quebec acquired a new position in Ingredion during the third quarter worth approximately $17,094,000. Finally, Allianz Asset Management GmbH raised its stake in Ingredion by 11.9% in the fourth quarter. Allianz Asset Management GmbH now owns 842,763 shares of the company’s stock valued at $115,930,000 after buying an additional 89,335 shares during the period. 85.27% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, CEO James P. Zallie sold 10,815 shares of the stock in a transaction that occurred on Wednesday, February 19th. The shares were sold at an average price of $125.88, for a total transaction of $1,361,392.20. Following the sale, the chief executive officer now owns 34,127 shares in the company, valued at approximately $4,295,906.76. This trade represents a 24.06 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 1.80% of the stock is owned by company insiders.

Ingredion Price Performance

NYSE:INGR opened at $129.22 on Thursday. Ingredion Incorporated has a 52 week low of $109.51 and a 52 week high of $155.44. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.69 and a current ratio of 2.62. The firm’s 50-day simple moving average is $132.29 and its 200 day simple moving average is $136.56. The firm has a market cap of $8.29 billion, a price-to-earnings ratio of 13.31, a P/E/G ratio of 1.03 and a beta of 0.74.

Ingredion (NYSE:INGR) last announced its earnings results on Tuesday, February 4th. The company reported $2.63 EPS for the quarter, topping the consensus estimate of $2.54 by $0.09. The company had revenue of $1.80 billion for the quarter, compared to analysts’ expectations of $1.82 billion. Ingredion had a net margin of 8.71% and a return on equity of 18.62%. The business’s revenue for the quarter was down 6.3% on a year-over-year basis. During the same period last year, the firm earned $1.65 earnings per share. As a group, sell-side analysts predict that Ingredion Incorporated will post 11.14 earnings per share for the current year.

Ingredion Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, January 21st. Investors of record on Thursday, January 2nd were given a $0.80 dividend. This represents a $3.20 dividend on an annualized basis and a dividend yield of 2.48%. The ex-dividend date of this dividend was Thursday, January 2nd. Ingredion’s payout ratio is currently 32.96%.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the company. UBS Group boosted their target price on Ingredion from $165.00 to $173.00 and gave the stock a “buy” rating in a report on Friday, November 15th. Stephens cut their target price on shares of Ingredion from $155.00 to $150.00 and set an “equal weight” rating for the company in a research note on Wednesday, February 5th. Oppenheimer reduced their target price on shares of Ingredion from $178.00 to $167.00 and set an “outperform” rating for the company in a report on Wednesday, February 5th. Barclays increased their price target on shares of Ingredion from $145.00 to $168.00 and gave the company an “overweight” rating in a report on Wednesday, November 6th. Finally, BMO Capital Markets reduced their price objective on Ingredion from $147.00 to $133.00 and set a “market perform” rating for the company in a report on Wednesday, February 5th. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat, Ingredion currently has an average rating of “Moderate Buy” and a consensus target price of $158.20.

Ingredion Company Profile

Ingredion Incorporated, together with its subsidiaries, manufactures and sells sweeteners, starches, nutrition ingredients, and biomaterial solutions derived from wet milling and processing corn, and other starch-based materials to a range of industries in North America, South America, the Asia Pacific, Europe, the Middle East, and Africa.